Palifermin as primary mucositis prophylaxis in patients with B-cell Non-Hodgkin lymphoma: a case series

Pediatr Hematol Oncol. 2022 Feb;39(1):80-82. doi: 10.1080/08880018.2021.1927271. Epub 2021 May 18.
No abstract available

Publication types

  • Letter

MeSH terms

  • Fibroblast Growth Factor 7 / therapeutic use
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Lymphoma, Non-Hodgkin* / complications
  • Lymphoma, Non-Hodgkin* / drug therapy
  • Mucositis* / drug therapy
  • Mucositis* / etiology
  • Mucositis* / prevention & control
  • Stomatitis* / drug therapy
  • Stomatitis* / prevention & control
  • Transplantation Conditioning

Substances

  • Fibroblast Growth Factor 7